Glyoxal: A possible polyvalent substitute for formaldehyde in pathology?;Le glyoxal : un possible substitut polyvalent du formaldéhyde en anatomie pathologique ?

Annales de Pathologie

Volumn 29, Issue 6, 2009, Pages 460-467

  Marcon, Nathalie ^a   Bressenot, Aude ^a   Montagne, Karine ^a   Bastien, Claire ^a   Champigneulle, Jacqueline ^a   Monhoven, Nathalie ^a   Albuisson, Eliane ^a   Plénat, François ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Fixation; Formaldehyde; Glyoxal; Pathology; Substitut

Indexed keywords

ANTIBODY; FORMALDEHYDE; GLYOXAL; NUCLEIC ACID; DISINFECTANT AGENT; DRUG DERIVATIVE; FIXATIVE; PRESERVATIVE;

ARTICLE; DILUTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MORPHOLOGY; PATHOLOGY; STANDARD; CHEMISTRY; GOVERNMENT; LEGAL ASPECT; TISSUE FIXATION; UNITED STATES;

DISINFECTANTS; FIXATIVES; FORMALDEHYDE; GLYOXAL; NUCLEIC ACIDS; PRESERVATIVES, PHARMACEUTICAL; TISSUE FIXATION; UNITED STATES; UNITED STATES OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION;

EID: 71549160345     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2009.09.011     Document Type: Article

References (17)

1. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans. Formaldehyde 2-Butoxyethanol and 1-tert-Butoxy-2-propanol (2006), IARC, Lyon
2. Bonnard N, Clavel T, Falcy M, Hesbert A, Jargot D, Protois JC, et al. Glyoxal et solutions aqueuses. Fiche toxicologique FT229. INRS;2005.
3. Bonnardel P. Le coefficient Kappa. http://kappa.chez-alice.fr/Kappa_fleiss.htm (consulté en mars 2008).
4. Dapson R.W. Glyoxal fixation: how it works and why it only occasionally needs antigen retrieval. Biotech Histochem 82 (2007) 161-166
5. Plenat F., and Duprez A. Man-nude mouse tissue chimera: characterization of cell population by in situ hybridization. C R Acad Sci III 310 (1989) 53-59
6. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 (2003) 2257-2317
7. Whipple Earl B. The structure of glyoxal in water. J Am Chem Soc 92 (1970) 7183-7186
8. Plénat F., Antunes L., Haller T., Piet-Ounnoughene M., Klein-Monhoven N., Champigneulle J., et al. La fixation formolée à l'aube du troisième millénaire. Ann Pathol 21 (2001) 29-47
9. Umlas J., and Tulecke M. The effects of glyoxal fixation on the histological evaluation of breast specimens. Hum Pathol 35 (2004) 1058-1062
10. Prento P., and Lyon H. Commercial formalin substitutes for histopathology. Biotech Histochem 72 (1997) 273-282
11. Titford M.E., and Horenstein M.G. Histomorphologic assessment of formalin substitute fixatives for diagnostic surgical pathology. Arch Pathol Lab Med 129 (2005) 502-506
12. Cotham W.E., Metz T.O., Ferguson P.L., Brock J.W., Hinton D.J., Thorpe S.R., et al. Proteomic analysis of arginine adducts on glyoxal-modified ribonuclease. Mol Cell Proteomics 3 (2004) 1145-1153
13. Yaziji H., and Gown A.M. Testing for HER-2/neu in breast cancer: is fluorescence in situ hybridization superior in predicting outcome?. Adv Anat Pathol 9 (2002) 338-344
14. Dako, IHC, Standardization. Connection 2007;10 [special issue].
15. Tubbs R.R., Hsi E.D., Hicks D., and Goldblum J. Molecular pathology testing of tissues fixed in prefer solution. Am J Surg Pathol 28 (2004) 417-419
16. Vincent R. Inventaire des agents chimiques CMR utilisés en France en 2005. INRS - Hygiène et sécurité au travail - Cahiers de notes documentaires 205 (2006) 83-96
17. American Conference of Governmental Industrial Hygienists. Threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, Ohio: ACGIH; 2004.